StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1062.16−22.27 (-2.05%)

Close on Nov 19, 2026Market cap $123.84BP/E 28.4Yield 0.30%

McKesson free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

McKesson's free cash flow for the twelve months ending Jun 30, 2026 was $6.42B, up 6.8% year over year. For fiscal 2026 it was $5.72B, up 3.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $5.72B in fiscal 2026.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 31, 2026$5.72B+3.1%
FY2025Mar 31, 2025$5.55B+42.9%
FY2024Mar 31, 2024$3.88B-18.6%
FY2023Mar 31, 2023$4.77B+17.9%
FY2022Mar 31, 2022$4.05B-1.1%
FY2021Mar 31, 2021$4.09B+2.0%
FY2020Mar 31, 2020$4.01B+11.1%
FY2019Mar 31, 2019$3.61B-8.4%
FY2018Mar 31, 2018$3.94B-9.2%
FY2017Mar 31, 2017$4.34B+36.3%
FY2016Mar 31, 2016$3.18B+16.4%
FY2015Mar 31, 2015$2.74B-4.3%
FY2014Mar 31, 2014$2.86B+27.5%
FY2013Mar 31, 2013$2.24B-17.8%
FY2012Mar 31, 2012$2.73B+29.6%
FY2011Mar 31, 2011$2.11B-0.6%
FY2010Mar 31, 2010$2.12B+83.1%
FY2009Mar 31, 2009$1.16B+71.5%
FY2008Mar 31, 2008$674.00M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$332.00M–
Q4 FY2026CQ1 2026Mar 31, 2026$3.31B-56.3%
Q3 FY2026CQ4 2025Dec 31, 2025$1.12B–
Q2 FY2026CQ3 2025Sep 30, 2025$2.31B+17.8%
Q1 FY2026CQ2 2025Jun 30, 2025-$1.03B–
Q4 FY2025CQ1 2025Mar 31, 2025$7.58B+91.4%
Q3 FY2025CQ4 2024Dec 31, 2024-$2.51B-1629.9%
Q2 FY2025CQ3 2024Sep 30, 2024$1.96B+120.7%
Q1 FY2025CQ2 2024Jun 30, 2024-$1.49B–
Q4 FY2024CQ1 2024Mar 31, 2024$3.96B+23.7%
Q3 FY2024CQ4 2023Dec 31, 2023$164.00M-89.5%
Q2 FY2024CQ3 2023Sep 30, 2023$890.00M-12.8%
Q1 FY2024CQ2 2023Jun 30, 2023-$1.13B–
Q4 FY2023CQ1 2023Mar 31, 2023$3.20B+16.3%
Q3 FY2023CQ4 2022Dec 31, 2022$1.56B+19.1%
Q2 FY2023CQ3 2022Sep 30, 2022$1.02B-39.9%
Q1 FY2023CQ2 2022Jun 30, 2022-$1.01B–
Q4 FY2022CQ1 2022Mar 31, 2022$2.75B-14.3%
Q3 FY2022CQ4 2021Dec 31, 2021$1.31B+19.7%
Q2 FY2022CQ3 2021Sep 30, 2021$1.70B+84.9%
Q1 FY2022CQ2 2021Jun 30, 2021-$1.72B–
Q4 FY2021CQ1 2021Mar 31, 2021$3.21B-29.2%
Q3 FY2021CQ4 2020Dec 31, 2020$1.09B–
Q2 FY2021CQ3 2020Sep 30, 2020$919.00M–
Q1 FY2021CQ2 2020Jun 30, 2020-$1.13B–
Q4 FY2020CQ1 2020Mar 31, 2020$4.53B+20.0%
Q3 FY2020CQ4 2019Dec 31, 2019-$237.00M–
Q2 FY2020CQ3 2019Sep 30, 2019-$147.00M-111.3%
Q1 FY2020CQ2 2019Jun 30, 2019-$138.00M–
Q4 FY2019CQ1 2019Mar 31, 2019$3.78B+30.8%
Q3 FY2019CQ4 2018Dec 31, 2018-$308.00M–
Q2 FY2019CQ3 2018Sep 30, 2018$1.30B+155.8%
Q1 FY2019CQ2 2018Jun 30, 2018-$1.16B-274.5%
Q4 FY2018CQ1 2018Mar 31, 2018$2.89B+126.2%
Q3 FY2018CQ4 2017Dec 31, 2017-$123.00M-143.0%
Q2 FY2018CQ3 2017Sep 30, 2017$509.00M-48.8%
Q1 FY2018CQ2 2017Jun 30, 2017$666.00M–
Q4 FY2017CQ1 2017Mar 31, 2017$1.28B–
Q3 FY2017CQ4 2016Dec 31, 2016$286.00M–
Q2 FY2017CQ3 2016Sep 30, 2016$994.00M–

More McKesson figures

See a number that looks wrong?